Aspire Biopharma Holdings, Inc. (ASBP) vs Bone Biologics Corporation (BBLG)

A side-by-side comparison of Aspire Biopharma Holdings, Inc. and Bone Biologics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aspire Biopharma Holdings, Inc. logo
ASBP
Aspire Biopharma Holdings, Inc.
$1M
$8.94HealthcareDelayed quote: Oct 6, 2026, 2:11 PM EDT
Bone Biologics Corporation logo
BBLG
Bone Biologics Corporation
$857758
$0.47HealthcareDelayed quote: Oct 6, 2026, 2:12 PM EDT

Total return — ASBP vs BBLG

growth of $100 · dividends reinvested · last 4y
ASBP -99.9% (-83.5%/yr)BBLG -100.0% (-87.6%/yr)ASBP compounded faster over this window
050100Start $1002023202420252026$0$0
ASBP BBLG

ASBP vs BBLG: by the numbers

  • •ASBP is the larger company ($1M vs $857758 market cap).
  • •Both run net losses; BBLG's is the smaller (0.00% vs -11314.24% net margin).

Metrics side by side

Valuation

MetricASBPBBLG
P/S ratio10.56N/A
P/B ratio0.090.22

Profitability

MetricASBPBBLG
Gross margin-1.87%0.00%
Operating margin-312016.95%0.00%
Net margin-11314.24%0.00%
ROE-93.97%-73.66%
ROIC-59.81%-78.01%

Go deeper

Full ASBP analysisFull BBLG analysisInteractive comparison tool

Dig into the metrics

Aspire Biopharma ROEBone Biologics ROEAspire Biopharma operating marginBone Biologics operating marginAspire Biopharma revenue growthBone Biologics revenue growthAspire Biopharma free cash flowBone Biologics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.